Boardroom Alpha
10-K primary document
MGTX · Annual Report (Form 10-K) · Filed March 30, 2026

Meiragtx Holdings PLC10-K exhibit

mgtx-20251231xex21.htm

Exhibit 21

SUBSIDIARIES OF MEIRAGTX HOLDINGS PLC

Legal Name of Subsidiary

  ​ ​ ​

Jurisdiction of Organization

BRI-Alzan, Inc.

Delaware

MeiraGTx B.V.

Netherlands

MeiraGTx Netherlands B.V.

Netherlands

MeiraGTx Limited

England and Wales

MeiraGTx, LLC

Delaware

MeiraGTx UK Limited

England and Wales

MeiraGTx UK II Limited

England and Wales

MeiraGTx Ireland DAC

Ireland

MeiraGTx Neurosciences, Inc.

Delaware

MeiraGTx Bio Inc.

Delaware

MeiraGTx Belgium

Belgium

MeiraGTx Therapeutics, Inc.

Delaware

MeiraGTx Neuro I, LLC

Delaware

MeiraGTx Neuro II, LLC

Delaware

MeiraGTx Manufacturing Limited

England and Wales

MeiraGTx Ocular UK Limited

England and Wales

MeiraGTx Gene Regulation Limited

England and Wales

MeiraGTx Neuro UK Limited

England and Wales

MeiraGTx Cell TherapiesFrance


Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer